Bruce Peacock

Filings by Bruce Peacock span 4 companies, the busiest being IVERIC bio, Inc., Windtree Therapeutics Inc and Ocular Therapeutix, Inc. Over a trading history stretching from 23 December 2008 to 3 December 2020, the count stands at 34 filings.

In open-market terms, that means 1 purchase worth €23k on one side and 16 sales worth €1.4M on the other. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 6 share grants and 10 option exercises. In 2020 alone, the filings show 1 purchase and 1 sale.

The newest entry dates from 7 December 2020: an option exercise of €58k, in Ocular Therapeutix, Inc. The last purchase on record was published on 27 May 2020, which is 2,357 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.